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New Self-Assembling Multifunctional Templates
for the Biofabrication and Controlled
Self-Release of Cultured Tissue
Ricardo M. Gouveia, PhD,1 Valeria Castelletto, PhD,2 Ian W. Hamley, PhD,2 and Che J. Connon, PhD1
The need to source live human tissues for research and clinical applications has been a major driving force for
the development of new biomaterials. Ideally, these should elicit the formation of scaffold-free tissues with
native-like structure and composition. In this study, we describe a biologically interactive coating that combines
the fabrication and subsequent self-release of live purposeful tissues using template–cell–environment feed-
back. This smart coating was formed from a self-assembling peptide amphiphile comprising a protease-
cleavable sequence contiguous with a cell attachment and signaling motif. This multifunctional material was
subsequently used not only to instruct human corneal or skin fibroblasts to adhere and deposit discreet multiple
layers of native extracellular matrix but also to govern their own self-directed release from the template solely
through the action of endogenous metalloproteases. Tissues recovered through this physiologically relevant
process were carrier-free and structurally and phenotypically equivalent to their natural counterparts. This
technology contributes to a new paradigm in regenerative medicine, whereby materials are able to actively
direct and respond to cell behavior. The novel application of such materials as a coating capable of directing the
formation and detachment of complex tissues solely under physiological conditions can have broad use for
fundamental research and in future cell and tissue therapies.
Introduction
One of the main challenges in tissue engineering is thecreation of a suitable environment, in which donor-
derived cells (such as stem cells) can be seeded, grown, and
induced to differentiate as they do in vivo toward the for-
mation of a complex tissue.1–3 This environment must be
suitable for proper cell attachment and/or migration, allow
nutrient and metabolite diffusion, and present adequate
biochemical and mechanical cues. There are numerous ex-
amples in the literature and in the clinic of artificial envi-
ronments that provide such a milieu of factors and
conditions,4–6 including smart or intelligent scaffolds that
respond to cells with culture progression.7–9 Some of these
scaffolds were developed using fully synthetic materials to
mimic the scale and chemistry of the natural extracellular
matrix (ECM).10–12 Peptide amphiphiles (PAs) constitute a
notable example of such synthetic materials.13–16 These
molecules have been used for their ability to self-assemble
in aqueous medium at physiological pH into highly ordered
nanostructures presenting specific peptide motifs at their
hydrophilic external surface, which then have the ability to
interact with cultured cells and initiate downstream signal-
ing cascades that regulate phenotype and ECM production
(as extensively reviewed in Refs.17–19).
Recently, several alternative scaffold-free technologies
have been developed to create suitable artificial environ-
ments able to instruct cells toward creating their own tissue
de novo.20 In this context, thermo-, electro-, photo-, and pH-
responsive materials have been developed to allow an easier
detachment of cells and tissues from the underlying tem-
plate.21 This bottom-up strategy is evidently attractive as it
provides cells with a template to fabricate native-like tissue
constructs containing an ECM resembling that of the natural
organ without the need of scaffolds or carriers. In addition,
by recapitulating differentiation and organogenesis in vitro
with patient-derived cells, these methods constitute an ex-
pedient alternative source of autologous tissue for clinical
applications.22 These techniques have been used mainly to
create cell sheets,23 with limited control on the tissues’
1Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
2School of Chemistry, Food and Pharmacy, University of Reading, Reading, United Kingdom.
ª R.M. Gouveia et al. 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative
Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,
distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
TISSUE ENGINEERING: Part A
Volume 21, Numbers 11 and 12, 2015
DOI: 10.1089/ten.tea.2014.0671
1772
three-dimensional structure and hierarchical organization,
and using nonphysiological triggers to induce detachment.
Furthermore, biologically interactive implants are gaining
considerable interest within the materials science commu-
nity. Thus, new methodologies are required that can be
easily incorporated into future transplantable medical de-
vices capable of directing cell and tissue formation and self-
regulated therapeutic release in physiological conditions.
To begin to address these challenges, we recently charac-
terized several self-assembling PAs carrying biofunctional
motifs24–26 shown to promote cell adhesion, proliferation,
and survival while enhancing stratification and controlling
the orientation of subsequent ECM deposition.27 This has
led to the present study, where we developed a bottom-up
strategy to create scaffold-free bioprosthetic tissues with
native-type structure and composition and under fully de-
fined physiological conditions. To this end, we developed a
novel, fully synthetic multifunctional PA (mfPA) comprising
a hydrophobic C16 aliphatic chain linked to a relatively
hydrophilic peptide sequence of 14 amino acids (Fig. 1a).
This peptide head was designed to perform as a multipur-
pose biofunctional cue comprising two contiguous bio-
active motifs, both derived from natural proteins. The
N-terminal sequence Thr-Pro-Gly-Pro-Gln-Gly-Ile-Ala-Gly-
Gln (TPGPQGIAGQ) was derived from the matrix me-
talloprotease (MMP) cleavage site of collagen type I and
functions as a specific proteolysis target for several MMPs,
namely MMP1 and 2,28 with predicted cleavage between the
Gly and Ile residues.29,30 The C-terminal sequence was the
integrin-dependent cell adhesion motif Arg-Gly-Asp-Ser
(RGDS) found in several cell adhesion molecules and used
extensively in biomaterial research, including similar PA
systems,31 to elicit cell attachment, promote survival, and
control cell encapsulation and phenotype.5
The rationale behind our specific design was to create a
defined supermolecular two-dimensional template able to
promote cell attachment, instruct the attached cells to syn-
thesize and deposit a tissue-specific ECM matrix, and ulti-
mately degrade through specific protease activity endogenous
to the newly formed tissue. Accordingly, it was shown that
by controlling the cleavage of the PA, the native-like tissue
was able to eliminate the adhesive properties of the original
template without requiring additional protease supplementa-
tion to the medium, and consequently induce its self-release
as a structurally intact live construct with potential down-
stream future applications.
FIG. 1. The multifunctional C16-TPGPQGIAGQRGDS peptide amphiphile (mfPA). (a) Schematic structure of mfPA
comprising a hydrophobic C16 aliphatic chain linked to a hydrophilic 14 amino acid peptide formed by an enzyme-responsive
sequence (in green;Yindicates the target site for matrix metalloprotease [MMP]-specific cleavage), followed by the integrin-
binding RGDS motif (red). (b) Critical aggregation concentration (c.a.c.) of mfPA in (i) single and (ii) binary systems mixed
with diluent PA at a 15:85 mol/mol ratio (mfPA:dPA). (c) Fourier transform infrared (FTIR) spectroscopy analysis of mfPA
(black) and mfPA:dPA (red) with corresponding peaks. Color images available online at www.liebertpub.com/tea
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Materials and Methods
Synthesis of PAs
PAs were custom synthesized by CS Bio as > 95% pure
trifluoroacetic acid salts and their molecular weight con-
firmed by electrospray mass spectrometry. Lyophilized C16-
TPGPQGYIAGQRGDS (mfPA;Yindicates cleavage site for
MMP1) and C16-ETTES (dPA)
32 were weighed and dis-
solved as single or binary component solutions in ultrapure
water from a Barnstead Nanopure system to the desired
concentrations. For binary PA systems, mfPA and dPA were
mixed in mol/mol ratios. The C16-GGGRGDS (sfPA),
24 C16-
TPGPQG, and IAGQRGDS molecules were similarly pre-
pared as single component solutions.
Cell culture
Corneal tissues were obtained as by-products of grafting
procedures and kindly provided by Mr. Martin Leyland,
BSc, MD, FRCOphth, following informed consent. All ex-
periments were approved by the Royal Berkshire NHS
Foundation Trust (RBFT) R&D Office and in accordance
with RBFT and MHRA ethics guidelines. Human corneal
stromal fibroblasts (hCSFs) were isolated from epithelia-
depleted corneal rings and cultured as previously described.33
For additional details, see the Supplementary Materials and
Methods section (Supplementary Data are available online
at www.liebertpub.com/tea).
Preparation of PA coatings
To produce thin, dry film coatings, 100mL aliquots from
PA solutions at 1 · 10- 5–10 - 2 M were spotted as& 1.5 cm2
drops onto standard or low-attachment, tissue culture plastic
surfaces (Nunc) and left to dry overnight at room tempera-
ture inside an aseptic, Class II cell culture cabinet. Resulting
films were washed thrice with sterile phosphate-buffered
saline (PBS) just before cell seeding. Stability of PA coat-
ings was assessed by imaging film coatings upon drying
(day 0) and after incubation in serum-free medium (SFM) at
37C for 7 days using a LumaScope inverted light micro-
scope (Etaluma). Conditioned medium enriched with endog-
enous MMPs (cSFM) was prepared by incubating confluent
hCSFs with SFM for 5 days immediately before use in
stability assays. MMP-free conditioned medium (RASFM)
was similarly produced while adding 1· 10- 5 M of all-trans
retinoic acid (RA; Sigma-Aldrich) every other day to inhibit
hCSFs from expressing MMPs.33
Adhesion and proliferation assays
To evaluate the biocompatibility and bioactivity of mfPA,
single and binary PA coatings were produced on low-
attachment, tissue culture plastic surfaces and then seeded
with 1.5 · 104 hCSFs$cm - 2 in serum-free culture medium
supplemented with 1 · 10- 5 M RA. Cell adhesion and pro-
liferation were evaluated using the AlamarBlue assay (Life
Technologies) according to the manufacturer’s instructions
(see the Supplementary Materials and Methods section).
Water-treated polystyrene surfaces were used as uncoated
control. To assess adhesion specificity, hCSFs were incu-
bated for 30 min with 5 · 10 - 5 M of dPA (mock), sfPA,
anti-aVb5 integrin antibody (ab24694; Abcam), or cyclo
[Arg-Gly-Asp(D-Phe)-NMe-Val] (cRGD; CS Bio) before
seeding, and the cell number was evaluated 24 h postseed-
ing. All experiments were performed in triplicate.
Analysis of gene marker expression
Cells seeded at 1.5 · 104 hCSFs$cm - 2 on 1.25 mM
mfPA:dPA at a 15:85 mol/mol ratio or dPA templates coating
normal cell culture plates were grown for 21 days in serum-
free culture medium supplemented with 1· 10 - 5 M RA, and
then harvested for mRNA isolation by standard Trizol ex-
traction (Life Technologies) and evaluation of gene ex-
pression as previously described27,33 (see the Supplementary
Materials and Methods section).
Biofabrication and self-release of 3D tissue
Coatings produced on low-attachment cell culture plates
using 1.25 mM mfPA:dPA at 15:85 mol/mol served as tem-
plates for adhesion, proliferation, and stratification of
hCSFs. Cells were seeded (5 · 104 cells$cm - 2) and cultured
for 90 days in SFM+ 1 · 10 - 5 M RA to allow the fabrica-
tion of an ECM-rich tissue, and then maintained in non-
supplemented SFM for 3 days to elicit MMP expression
and consequent tissue self-release. Tissue detachment was
monitored by following removal of RA from the culture
medium by time-lapse bright-field microscopy using a
remote-operated LumaScope inverted microscope inside the
tissue incubator.
Reattachment assays
Self-released tissues (R1) were sampled using a reusable
3-mm Harris micropunch (Sigma-Aldrich) and then recon-
ditioned in RA-supplemented SFM for 3 days to suppress
MMP expression endogenous to the tissue. Reconditioned
tissues were then transferred to new uncoated or mfPA:dPA-
coated low-attachment plates and maintained in RA-
supplemented SFM. A glass coverslip was used to hold the
tissue plane in close contact with the surface. After 7 days,
glass coverslips were removed and tissues were washed with
PBS and imaged from above and diagonally using a Pentax
Optio 750Z digital camera (Pentax). Tissues attached to the
mfPA:dPA coating were then released as before by removal
of RA from the culture medium. These second-time self-
released tissues (R2) were again sampled, and the re-
attachment/redetachment process repeated for a third time
(R3). Samples were used immediately after punching to
evaluate cell viability using the Live/Dead Cell double
staining kit (CalBioChem; Merck) according to the manu-
facturer’s instructions. Calcein- and propidium iodide-stained
cells were imaged using an Axio Imager fluorescence mi-
croscope (Zeiss) at lem = 515 and 620 nm, respectively.
Quantification of total viable cells was performed by ana-
lyzing 10 different fields per sample from 3 independent
samples.
Contraction assays
Free-floating self-released tissues, R1, R2, and R3, were
imaged (day 0) using a Nikon D90 digital camera (Nikon)
and then incubated in cell culture medium containing 5%
fetal bovine serum (FBS) to elicit myofibroblast differenti-
ation of hCSFs. After 7 days, tissues were again imaged
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(day 7) and contraction evaluated by calculating the ratio
between the initial and final areas for each tissue using the
ImageJ v1.46 software.
Statistical analysis
Error bars represent the standard deviation of the mean,
analyzed a priori for homogeneity of variance. Replicates
from each independent experiment were confirmed to follow
a Gaussian distribution, and differences between groups
were determined using one- or two-way analysis of vari-
ance, followed by Bonferroni’s multiple comparison post
hoc test. Significance between groups was established for
p < 0.05, 0.01, and 0.001, with a 95% confidence interval,
and R2 values of 0.7585, 07591, 0.9031, 0.9291, and 0.9814
for the proliferation, gene expression, contraction, viability,
and MMP1 expression assays, respectively.
Results and Discussion
Biophysical characterization of the PAs
The mfPA was solubilized from lyophilized powder in
ultrapure water and its critical aggregation concentration
(c.a.c.) determined by Thioflavin T (ThT) fluorescence was
1.1 · 10 - 3 M (Fig. 1b, upper panel). Fourier transform in-
frared (FTIR) spectroscopy experiments above the c.a.c.
showed that mfPA self-assembled with a secondary b-sheet
structure, as is denoted by the positive band at 1620 cm - 1
(Fig. 1c), suggesting its arrangement into highly organized
structures.24 This was supported by transmission electron
microscopy (TEM), which showed that mfPA forms well-
defined polydisperse nanotapes, 528 – 83 A˚ wide (Fig. 2a),
displaying 5.6 – 0.8 A˚-thick stripes along the main axis of
the fiber (Fig. 2a, left inset), expectedly associated with the
internal lamellar structure of the nanotapes.24
The sensitivity of mfPA (m/z 1578.87) to specific cleavage
by metalloproteases was analyzed by mass spectrometry
after incubation of mfPA nanotapes with MMP1. This en-
zyme specifically recognized the cleavage sequence de-
signed for mfPA, producing the expected peptide fragment,
IAGQRGDS, detected at m/z 803.43 (Fig. 2b). A smaller
moiety corresponding to the GQRGDS peptide was also
detected at m/z 619.3, indicating some residual proteolytic
cleavage or degradation. However, the cleavage product,
C16-TPGPQG, was not detected by mass spectrometry. This
product self-assembled above 8.6 · 10 - 5 M (Supplementary
Fig. S1) and formed micelle-like structures (Supplementary
Fig. S2) similar to those observed in MMP1-treated mfPA
(Fig. 2b). In contrast, no self-assembly was detected for the
IAGQRGDS peptide (Supplementary Fig. S1). These results
suggested that, upon cleavage of the mfPA by MMP1, the
RGDS-containing peptide is released into the medium,
whereas the newly formed C16-TPGPQG fragment remained
assembled within the pre-existing nanotapes, forming dis-
tinct self-assembling structures. The specificity of cleavage
was further tested by incubating mfPA with proteolysis
buffer only or with recombinant MMP7. MMP7 was pre-
viously shown to be expressed by various cell types, in-
cluding hCSFs,34 but unable to target the MMP-cleavage
sequence included in the mfPA.
29,35 No cleavage products
were obtained after these treatments (Fig. 2b), demonstrat-
ing that the cleavable motif of the mfPA is recognized only
by specific proteases.
Several studies have shown that the bioactivity of PAs
containing cell adhesion motifs can be augmented using
FIG. 2. Specific degradation of mfPA by MMP1. (a) Transmission electron micrographs of self-assembled structures
comprising mfPA and mfPA:dPA. In aqueous solution, these PA systems formed well-defined polydisperse nanotapes
(control) that degrade when treated with a protease able to recognize the enzyme-responsive sequence of mfPA ( +MMP1).
Scale bars, 500 nm (insets, 50 nm). (b) Enzyme-catalyzed cleavage of mfPA in solution. The products of the reaction with
enzymes that cleave ( +MMP1) or are unable to recognize the enzyme-responsive sequence of mfPA ( +MMP7) were
analyzed by mass spectrometry and compared with enzyme-free control ( + buffer).
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diluent PA molecules to space the bioactive molecules in the
assembled nanostructure,27,36 thus creating binary PA sys-
tems that minimize interaction between bioactive motifs.32
Recently, we have used the nonbioactive, negatively
charged C16-Glu-Thr-Thr-Glu-Ser molecule (hereby desig-
nated dPA) as such a diluent to achieve the optimal cell
adhesion activity of an RGDS-containing PA.27 Similarly,
we produced a binary PA system by combining mfPA with
dPA in water. ThT fluorescence analysis showed that the
c.a.c. of the mixed system was five times lower than single-
system mfPA (Fig. 1b), indicating that the aggregation
process was driven by the dPA, probably due to its higher
degree of hydrophobicity. FTIR for mfPA:dPA denoted a
b-sheet secondary structure with a positive band at 1620 cm-1
(Fig. 1c). The existence of a single c.a.c. for the binary
mfPA:dPA system suggested an interaction between mfPA
and dPA molecules. Additional evidence was found by
TEM, where the self-assembly of the mixed binary sys-
tem led to the formation of nanotapes, 254 – 41 A˚ wide
(Fig. 2a), displaying stripes similar to those observed for
single-system mfPA (Fig. 2a, right inset). Furthermore,
these nanotapes were also sensitive to cleavage by the
proteolytic activity of MMP1 (Fig. 2a, bottom right panel).
Altogether, these results indicate that mfPA:dPA coas-
sembled and formed homogeneous nanostructures where
the bioactive enzyme-responsive mfPA is interspersed with
dPA molecules.
Bioactivity of the PA templates
The bioactivity of single and mixed PA systems was
tested by evaluating the potential of mfPA and mfPA:dPA to
promote integrin-dependent cell attachment and direct cell
phenotype. For that, various concentrations of PAs in so-
lution were drop-spotted and dry-coated onto low-attach-
ment cell culture plates, allowing the formation of thin film
coatings (Fig. 3). The stability of these films was tested after
incubation with SFM previously conditioned by hCSFs
(cSFM, containing secreted MMPs). As controls, MMP-free
media, that is, fresh SFM or medium conditioned in the
presence of all-trans RA (RASFM), were used. RA is a
metabolite of vitamin A that suppresses MMP expression
while enhancing ECM production from various cell types,
namely hCSFs33 and skin fibroblasts.37 The results demon-
strated that, after 7 days in cSFM, mfPA and mfPA:dPA films
were partially removed with considerable fraying and deg-
radation of the edges (Fig. 3, cSFM). In contrast, when in-
cubated with MMP-free media (Fig. 3, SFM or RASFM), the
films remained intact and comparable as before incubation
(Fig. 3, day 0). This effect was shown to be specific to films
containing the mfPA molecule as films comprising a single
function PA, sfPA (i.e., with the RGDS motif, but without
the MMP-cleavable sequence27), were not degraded in
cSFM (Fig. 3). These results further suggested that the
supplementation of cell culture medium with RA constituted
a simple and reliable method to control the cleavage of
mfPA, and consequently, to regulate the ability of mfPA-
containing coatings to provide a template for cell attach-
ment. Moreover, the use of RA as a medium supplement
was physiologically relevant as this metabolite has been
shown to play a fundamental role in the correct develop-
ment, function, and regeneration of many organs,38 as well
as in cancer prevention.39 As such, RA was supplemented to
SFM in subsequent cell culture experiments, unless other-
wise noted.
The optimal bioactivity of the film coatings was assessed
for mfPA mixed with dPA in ratios from 0:100 (dPA only) to
100:0 mol/mol (mfPA only) and at final concentrations of
FIG. 3. Stability of PA
coatings. Self-assembled
mfPA and mfPA:dPA struc-
tures dry-coated on cell cul-
ture surfaces produced
continuous films (day 0) that
degraded after incubation
with conditioned culture me-
dium (cSFM), but remained
stable in MMP-free media
(serum-free medium [SFM]
or RASFM). This effect was
specific to mfPA-containing
coatings and not to functional
PAs without an MMP-
responsive sequence (sfPA).
Scale bars, 20mm.
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1 · 10- 5–10 - 2 M. The activity of the different PA coatings
was assessed by counting the number of attached hCSFs
after 7 days in culture. Low-attachment plates were used as
the underlying culture surface to minimize cell adhesion on
uncoated areas. The results showed that all coatings con-
taining mfPA were able to support cell adhesion and pro-
liferation, whereas dPA coatings (0:100 ratio) and uncoated
controls were not (Fig. 4). Cells grown on biofunctional
adhesive coatings assumed an extended fibroblast-type
morphology similar to that presented by cells attached to
standard polystyrene culture surfaces, but those on dPA re-
mained round shaped (Fig. 4a). The adhesive activity of the
coatings was shown to be dependent on mfPA concentration
up to 1.25 · 10- 3 M and on the PA ratio, with an optimum at
15:85 mol/mol mfPA:dPA. Furthermore, these coatings were
shown to bind cells specifically and dependently on aVb3
integrins (Supplementary Fig. S3). PA coatings above
1.25 · 10- 3 M were shown to be toxic to the cells attached
in the early stage of culture, inducing cell death and con-
sequent detachment (Fig. 4b). Thus, we hypothesize that the
optimal bioactivity found for the 15:85 mol/mol ratio re-
sulted from a balance between the highest epitope density
and the lowest epitope crowding effect. Moreover, the sus-
ceptibility to degradation by MMPs observed for this binary
PA system in solution (Fig. 2) and as a coating (Fig. 3) was
not due to the presence of the dPA as coatings produced
solely from dPA were stable in cSFM (Supplementary Fig.
S4). As such, to maximize the interaction between the sur-
face coating and cells, all further experiments were per-
formed using the 15:85 mol/mol mfPA:dPA binary system.
Integrin-mediated cell adhesion has been shown to mod-
ulate gene and protein expression and control cell pheno-
type.40 Previous studies have shown that, when cultured in
serum-free media, hCSFs revert to a characteristic alpha
smooth muscle actin (aSMA)-negative phenotype and ex-
press a defined panel of markers that include keratocan,
lumican, decorin, and aldehyde dehydrogenase A1 (ALDH1),
all of which are fundamental for the function of the native
tissue.41,42 In this context, the effect of mfPA:dPA coating on
the expression of several hCSF gene markers was evaluated
FIG. 4. The adhesive and prolifera-
tive bioactivity of mfPA. (a) The
adhesive properties of mfPA and
mfPA:dPA coatings allowed human
corneal stromal fibroblasts (hCSFs) to
attach on low-attachment cell culture
plates (upper panels) as in normal
culture polystyrene surfaces (lower
panels). This effect was dependent on
the RGDS motif of mfPA and not ob-
served in nonbioactive dPA coatings.
Scale bars, 20mm. (b) Effect of con-
centration and the mfPA:dPA dilution
ratio on hCSF proliferation. Cells
grown on PA films coating low-
attachment surfaces were counted
after 7 days in culture. Proliferation
increased with increasing PA concen-
tration up to 1.25 mM, after which PA
coatings induced cell death. In all vi-
able coatings, maximum proliferative
effect was observed for mfPA:dPA at
the 15:85 mol/mol ratio. No attach-
ment was observed in noncoated (n/c)
or dPA-coated surfaces (0:100 ratio).
Data are expressed as average –
standard deviation (SD) of three
independent experiments (n= 3);
*** corresponded to p < 0.001. Color
images available online at www
.liebertpub.com/tea
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by reverse transcription quantitative–polymerase chain re-
action and compared with that of cells on dPA-coated and
uncoated surfaces (Fig. 5). In this particular assay, normal
cell culture polystyrene plates were used to allow cells to
adhere and grow, irrespectively of the coating. Importantly,
hCSFs grown on bioactive mfPA:dPA coatings showed sig-
nificant upregulation for genes coding for keratocan, lumi-
can, decorin, and ALDH1 (KERA, LUM, DCN, and ALDH1,
respectively) compared with cells on nonbioactive dPA
coatings (Fig. 5). However, no effect was observed in the
transcription levels of ACTA2 (the gene coding for aSMA, a
marker of myofibroblastic differentiation43) or MMP1 (Fig.
5). Furthermore, no differences in gene expression were
observed between cells grown on dPA-coated and uncoated
surfaces (data not shown). Together, these results showed
that the bioactive PA not only promoted cell adhesion but
also directed cell phenotype by enhancing the expression of
several specific ECM components without compromising
the proven MMP repression effect from RA supplementa-
tion to cultured hCSFs.33
Controlled degradation of PA template
and tissue self-release
The potential of mfPA:dPA to act as a template capable of
inducing the formation of self-releasable tissues under
physiological conditions was tested by coating it onto low-
attachment culture plates. These plates were subsequently
used for the adhesion and long-term culture of hCSFs in
serum-free RA-supplemented medium (Fig. 6a). Under these
conditions, cells were able to attach, proliferate, and survive
for 90 days (Fig. 6b and c) without compromising the adhe-
sive PA surface. The combined effects from mfPA:dPA in-
teraction and RA signaling33 ensured that cells proliferated
up to day 60 (Fig. 6b and c, d60) and stratified from day 30
onward, creating a multilayered construct comprising a cell-
derived dense tissue within the boundaries of the PA tem-
plate (Fig. 6b, d30–d90). Concomitantly, cells maintained in
RA-supplemented medium suppressed MMP expression,
with corresponding culture supernatants presenting MMP
activities below 5% of that from nonsupplemented condi-
tioned medium (Fig. 7). As such, newly formed tissue was
cumulatively deposited by cells, and no visible degradation
was observed for the entire 90-day period of culture (Fig.
6b). After 90 days in culture, the PA-instructed hCSFs were
able to fabricate structurally representative corneal tissue,
with an interwoven matrix comprising densely packed col-
lagen fibers and associated native-type proteoglycans, such
as keratocan, lumican, and decorin (Fig. 8). These proteo-
glycans only partially colocalized with the collagen fibers,
also occupying the space between the collagenous matrix
and the cell layers (Fig. 8, blue staining; also Supplementary
Figs S5–S7).
Upon formation of the biofabricated constructs at day 90,
tissue cultures were then maintained in the medium without
RA (Fig. 6a), and MMP proteolytic activity was monitored
each day for 3 days (days + 1, + 2, and + 3). Removal of RA
supplementation resulted in a cumulative increase of pro-
teolytic activity in the culture supernatant over time (Fig. 7),
a consequence of MMPs being expressed from cells within
the tissue constructs. Although MMP activity at day + 3
corresponded to only 45%– 13% of that from conditioned
medium, it allowed the newly formed tissues to completely
detach from the surface of the culture plate and emerge
(Fig. 6a and Supplementary Video S1). This indicated that,
by day + 3, the MMP activity accumulated in the medium
was sufficient to cleave the RGDS motif from the mfPA:dPA
nanotapes and degrade the adhesive coating template (Fig.
6a). The subsequent self-release and liftoff of the tissue at day
+ 3 resulted in a small, but significant, loss of cells (Fig. 6c).
However, the free-floating construct maintained its structural
integrity (Fig. 9 and Supplementary Video S2), with no ap-
parent loss of the dense ECM present at d90 (Fig. 6b, + 3).
Similarly, skin fibroblasts seeded onto the PA surface
templates and cultured for 90 days in RA-supplemented
SFM were able to attach, proliferate, and fabricate ECM-
dense three-dimensional tissues. Following the same method
of RA removal, the newly formed skin tissues were able to
express endogenous MMPs, thus degrading the adhesive PA
template and promoting their self-detachment while retain-
ing structural integrity and shape (Supplementary Video
S3). These results indicated that more than one cell type can
be applied to this PA system and to produce easily recov-
erable structurally intact tissues through the physiologically
relevant RA supplementation/removal mechanism. How-
ever, for cell types where RA is not a feasible regulator of
endogenous MMP expression, alternative systems could be
used with predictably similar results. For example, alterna-
tive inhibitors of MMP expression (such as the anticancer
agents Marimastat,44 Ro 28-2653,45 and doxycycline46) or
enzymatic activity (e.g., tissue inhibitors of metalloprotei-
nase or a2-macroglobulin
47) could be added throughout the
culture process, and then removed to transiently increase
MMP activity and elicit the degradation of the PA tem-
plate and tissue release.
Functional characterization of self-released
tissue equivalents
To further characterize the efficacy of the self-release
process, the viability, ultrastructure, and function of the
FIG. 5. Effect of mfPA on the molecular phenotype of hCSFs.
Relative expression of genes coding for hCSF-characteristic
extracellular matrix (ECM) components (KERA, LUM, DCN,
and ALDH1) was significantly increased in cells grown
for 21 days on mfPA:dPA (grey) when compared with dPA
coatings (white bars). Data are expressed as average – SD
of three independent experiments (n= 3); * and ** corre-
sponded to p < 0.05 and 0.01, respectively.
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self-lifted tissues were analyzed. Tissue function and via-
bility were tested by determining the capacity of the corneal
stromal constructs to reattach to an adhesive surface after
MMP-induced self-release while maintaining their constit-
uent cells alive. For this, first-time self-released tissues (R1)
were punch-sampled to assess cell viability through a live/
dead cell assay, reconditioned in RA-containing medium for
3 days to suppress MMP expression, and then transferred to
a new mfPA:dPA-coated, low-attachment cell culture plate
for reattachment (Fig. 6a). After 7 days, tissue constructs
were shown to be planar and strongly attached to mfPA:dPA-
coated surfaces (Fig. 10a, R1), but not to uncoated controls
where they remained free-floating (Fig. 10a, uncoated).
Furthermore, the viability of cells comprising the tissue was
maintained with 92%– 1% of live cells (Fig. 10b and c, R1).
The ultrastructure of R1 corneal stromal tissues was evalu-
ated by TEM (Fig. 10d). These 10.1 – 1.8-mm-thick bio-
constructs comprised two or three cells layers separated by
2.6 – 1.6-mm-thick regions of ECM (Fig. 10d, upper panel)
characterized by densely packed collagen fibrils with an
average diameter of 27.6 – 2.8 nm and a d-spacing of
58.5 – 4.5 nm (Fig. 10d, lower panels). Interestingly, the
ECM thickness of these tissues was similar to that of stromal
lamellae (i.e., the building blocks) of native human cor-
neas.48 Moreover, the calculated diameter and d-spacing
parameters were comparable with those of collagen type I
fibers found in the human cornea,48,49 representing an im-
provement over similar tissue constructs produced de novo
by diverse methods.50,51 These results were consistent with
those obtained by confocal immunofluorescence microscopy
(Fig. 8) and constituted proof that the tissue fabric produced
in vitro by hCSFs grown in mfPA:dPA-coated surfaces was
remarkably similar to that of the native corneal stroma.
The endurance of the tissue constructs was further tested
by repeating the relift, punching, and reattachment processes
two additional times, consecutively (Fig. 6a). Second-time
FIG. 6. Proof of concept for the use of mfPA as a template to induce the biofabrication and control the self-release of tissues
by donor-derived cells. (a) Schematic diagram depicting how cells isolated from human donors were seeded and grown on
low-attachment plates coated with 1.25 mM mfPA:dPA at the 15:85 mol/mol ratio (green) in retinoic acid (RA)-supplemented
SFM (blue). Tissues fabricated in the course of the 90-day culture period were induced to express MMPs into the culture
supernatant after RA removal from the medium (orange), thus providing the cue to degrade the adhesive PA coating and
induce their self-release (blue arrows). Lifted tissues were then easily recoverable for downstream applications, namely for
thrice-repeated reattachment and relifting processes, using only RA-induced regulation of endogenous MMP expression. (b)
Phase-contrast micrographs of hCSFs growing as a monolayer on mfPA:dPA templates (day [d]7) and integrating the tissue
formed by PA-induced ECM deposition and accumulation before (d30–d90), during (+ 3), and after tissue self-release (R1).
Scale bars, 100mm. (c) Proliferation of hCSFs grown on mfPA:dPA templates. Cell proliferation in RA-containing SFM (blue
bars) increased up to day 60, and then decreased at day 90 and in the following 3 days, when incubated in SFM without
RA (white bars, + 1, + 2, and + 3). Data are expressed as average–SD of three independent experiments (n= 3); * and
** corresponded to p< 0.05 and 0.01, respectively. Color images available online at www.liebertpub.com/tea
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released tissues (R2) were always able to reattach to coated
surfaces while maintaining shape throughout the manipu-
lation process (Fig. 10a). In addition, cell viability remained
high with R2 tissues maintaining 85% – 13% of live cells
(Fig. 10b, c), representing maintenance of cell viability
within the tissue for 13 days following initial release (Fig.
6a). Reattachment was even observed after three consecu-
tive self-releases (Fig. 10a, R3), despite evidence of some
structural damage and a significant reduction in cell viability
to 40%– 2% (Fig. 10c). These results demonstrate that the
fabricated tissue constructs were very robust, being able to
respond to RA deprivation, control their MMP-mediated
self-release, and then be RA reconditioned and reattach to
an adhesive surface three consecutive times. In addition,
tissues remained structurally whole and morphologically
intact despite their thickness and the endogenous MMPs
FIG. 7. MMP activity from cell culture supernatants. (a)
Representative casein gel zymogram and (b) corresponding
densitometry analysis of supernatant samples collected from
5-day conditioned medium (cSFM) and from various time
points where cells were cultured with (blue) or without RA
(white bars). Data are expressed as average – SD of three
independent experiments (n = 3); ** and *** corresponded
to p < 0.01 and 0.001, respectively. Color images available
online at www.liebertpub.com/tea
FIG. 8. Immunofluorescence confocal microscopy of self-detached tissue constructs. (a) Representative top view and (b)
z-stack view of corneal tissues fabricated by hCSFs grown on mfPA:dPA templates for 90 days. Tissue constructs showed
that they comprise multiple layers of collagen type I fibers (red) deposited between actin-stained cells (green) and form an
ECM enriched with hCSF-characteristic proteoglycans (blue), such as keratocan (left), lumican (center), and decorin (right
panels). Scale bars, 20mm. Color images available online at www.liebertpub.com/tea
FIG. 9. Photograph of free-floating, human corneal tissue
fabricated by hSCFs. Tissue constructs fabricated by cells
during 90 days recovered their ability to express MMPs after
being maintained in SFM without RA. The endogenous
MMPs expressed by the tissue were capable of degrading
the underlying mfPA:dPA template after 3 days, thus induc-
ing the tissue self-release from its adhesive bottom surface
without any external manipulation. The resulting free-
floating tissue was transparent in water and retained its
original shape and structural integrity. A decimal ruler was
used as scale.
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eliciting tissue self-release. These results also suggested
that self-released tissue constructs could perform well as
live transplantable equivalents. Cell sheet constructs used as
corneal,52 esophageal,53 tracheal,54 myocardial,55 and he-
patic56 implants have previously shown improved practical
and functional advantage due to their intrinsic ability to
attach to the recipient organ without the need for sutures or
carrier materials, leading to quicker graft integration and
organ regeneration.57 As such, the demonstrated ability of
the self-released tissues to reattach to adhesive surfaces
represents a promising clinical application.
The specific function of cells within the released tissues
was also evaluated. It is known that hCSFs play a funda-
mental role in response to corneal injury in vivo by as-
suming a contractile myofibroblastic phenotype.43 This
cellular function was simulated here by exposing free-
floating, corneal stromal tissues after self-release to FBS for
7 days (Fig. 11a). The results showed that R1 tissues con-
tracted to 8%– 3% of their initial area (Fig. 11b), indicating
that cells comprising the tissue constructs were activated
and contractile. The hCSFs comprising second- (R2) and
third-time self-released tissues (R3) were also prone to ac-
tivation, as demonstrated by tissue contraction to a corre-
sponding 9%– 5% and 32%– 5% of their initial size (Fig.
11). The reduced contraction from R3 could be explained
by the lower number of resident hCSFs within those tissues
(Fig. 10c). However, the cells remaining alive were still
capable of performing a change in phenotype and activat-
ing into myofibroblasts. Together, these results showed that
tissue fabricated in vitro by hCSFs grown on mfPA:dPA
templates were structurally and functionally similar to na-
tive stromal tissue from human corneas and that the con-
trolled self-release resulting from the specific degradation of
the adhesive mfPA:dPA coating allowed an easy tissue re-
covery (Supplementary Video S2) with minimal damage to
its cells or ECM structure. Furthermore, even after extensive
manipulation, the tissues were able to reattach and relift
three consecutive times while remaining functionally active
for an additional 26-day period in culture, as demonstrated
by the contraction assay.
FIG. 10. Macro-, micro-,
and ultrastructural stability
of tissues fabricated and self-
released from PA templates.
(a) Reattachment of biofab-
ricated tissues after one (R1),
two (R2), or three consecu-
tive self-detachments (R3) to
low-attachment plates with
or without (uncoated)
mfPA:dPA. Self-released tis-
sues were punch-sampled
and reconditioned in RA-
supplemented SFM before
being transferred for re-
attachment (Fig. 6a). Scale
bars, 3 mm. (b) Live and
dead hCSFs integrating the
self-released tissues imaged
by fluorescence microscopy
using calcein (green)/propi-
dium iodide (red) cell stain-
ing (Scale bars, 20 mm), and
(c) corresponding cell via-
bility was calculated for R1,
R2, and R3 tissue constructs.
Data are expressed as aver-
age – SD of three indepen-
dent experiments (n = 3); **
corresponded to p < 0.01. (d)
Ultrastructure of R1 was
observed by transmission
electron microscopy, evi-
dencing the multilayered or-
ganization of the tissue
(upper panel), with inter-
calating layers of hCSFs and
deposited ECM comprising
densely packed collagen fi-
brils (lower panels). Scale
bars, 500 nm (upper),
100 nm (lower panels). Color
images available online at
www.liebertpub.com/tea
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Conclusions
In light of our results, we postulate that the use of mul-
tifunctional PA templates constitutes a promising strategy to
fabricate native-like tissue sheets in vitro. First, the mfPA is
a simple molecule that spontaneously self-assembles in
aqueous medium in single or binary systems at relatively
low concentrations. Second, the resulting nanostructures
produced stable biofunctional templates by dry coating, a
quick, simple, and highly transferable method. Third, PA
nanostructures can be assembled from multiple molecules.
Thus, it is reasonable to assume that more than one bio-
functional PA can be added to the system to create a more
complex template, that is, one that can fine-tune cell be-
havior through consecutive or sequential activation of mul-
tiple signaling pathways. The potential of multicomponent
PAs is well demonstrated in our mfPA:dPA templates, where
the diluent dPA molecule significantly increased the bioac-
tivity of the RGDS motif. Through this motif, mfPA:dPA
coatings were able to instruct cells isolated from human
donors to fabricate native-like corneal or skin bioconstructs
while simultaneously controlling tissue adhesion to the
surface. As release occurs through degradation of the coat-
ing PA, no external carrier is present upon tissue recovery,
nor is it required due to the tissues’ intrinsic robustness. The
ability to retain shape and reattach represents a promising
feature for tissue/organ engineering58 and grafting,57 mak-
ing these biofabricated constructs suitable for transplanta-
tion applications. Individual constructs can also be folded or
stacked to increase tissue thickness and evaluate its optical
properties (i.e., transparency).
Overall, these properties make the mfPA a highly trans-
ferable versatile material that, pending future comparative
studies, can represent a physiologically integrated alterna-
tive to other scaffold-free bottom-up strategies used to
create tissues in vitro.59 As such, this smart material will
provide a plausible platform for the biofabrication of certain
tissues to source autologous transplantation. Furthermore,
due to the material’s ability to proceed under physiological
conditions, we envision its use in the creation of new im-
plantable medical devices for cell therapy applications, both
capable of directing the growth and subsequent release of
therapeutic cells/tissues within locations known to have
varying MMP levels, such as in developing tumors or during
wound healing.
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